✦ LIBER ✦

Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate is Not yet Closed

✍ Scribed by Pierre-Jean Guillausseau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to the letter by P. Guillausseau R

✍ Bo Ahrén 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 43 KB

Serum level of soluble CD26/dipeptidyl p

✍ Yoshimasa Aso; Noriyuki Ozeki; Tomoko Terasawa; Rika Naruse; Kenji Hara; Mariko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 210 KB

The safety of dipeptidyl peptidase-4 (DP

✍ Kawalec, Paweł ;Mikrut, Alicja ;Łopuch, Sylwia 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

Efficacy and safety of the dipeptidyl pe

✍ Kobayashi, K.; Yokoh, H.; Sato, Y.; Takemoto, M.; Uchida, D.; Kanatsuka, A.; Kur 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

PDB17 Comparison of Clinical and Economi

✍ Bron, M.; Chen, K.; Cheng, D.; Bensimon, A.G.; Wu, E.Q. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB